The Enterococcus secretome inhibits the growth of vancomycin-resistant Enterococcus faecalis V853 with their antiproliferative properties and nanoencapsulation effects-Reference-Cited by-同舟云学术

The Enterococcus secretome inhibits the growth of vancomycin-resistant Enterococcus faecalis V853 with their antiproliferative properties and nanoencapsulation effects

Published:2024-05-22 Issue: Volume: Page:
ISSN:1618-1905
Container-title:International Microbiology
language:en
Short-container-title:Int Microbiol

Author:

Youssef Hadeer,Azmy Ahmed F.^ORCID,Eid Hussein M.^ORCID,Sayed Ossama M.^ORCID,Eldomany Ehab B.^ORCID,Farghali Ahmed A.,Molham Fatma^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s10123-024-00534-6.pdf

Reference93 articles.

1. Abanoz HS, Kunduhoglu B (2018) Antimicrobial activity of a bacteriocin produced by enterococcus faecalis kt11 against some pathogens and antibiotic-resistant bacteria. Korean J Food Sci Anim Resour 38:1064–1079

2. Abele-Horn M, Vogel U, Klare I, Konstabel C, Trabold R, Kurihara R, Witte W, Kreth W, Schlegel PG, Claus H (2006) Molecular epidemiology of hospital-acquired vancomycin-resistant enterococci. J Clin Microbiol 44:4009–4013

3. Achache W, Mege JL, Fellag M, Drancourt M (2023) The Enterococcus secretome inhibits the growth of Mycobacterium tuberculosis complex mycobacteria. Access Microbiol 5:000471−v3

4. Akhtar N, Sultan F, Nizamuddin S, Zafar W (2016) Risk factors and clinical outcomes for vancomycin-resistant enterococcus bacteraemia in hospitalised cancer patients in Pakistan: a case-control study. J Pak Med Assoc 66:829–836

5. Al-Fakharany OM, Aziz AA, El-Banna TES, Sonbol FI (2018) Immunomodulatory and anticancer activities of Enterocin Oe-342 produced by Enterococcus feacalis isolated from stool. J Clin Cell Immunol 09(9):558